This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.

Phreesia, Inc.
3/12/2025
Good evening, ladies and gentlemen, and welcome to the Frisia's fourth quarter fiscal 2025 earnings conference call. At this time, all participants are in listen-only mode. We will provide instruction for the question and answer session to follow. First, I would like to introduce Palachi Gandhi, Frisia's chief financial officer. Mr. Gandhi, you may begin.
Thank you, operator. Good evening, and welcome to Frisia's earnings conference call for the fourth quarter of fiscal 2025. which ended on January 31st of 2025. Joining me on today's call is Haim Indig, our Chief Executive Officer. A more complete discussion of our results can be found in our earnings press release and in our related form 8K submission to the SEC, including our quarterly stakeholder letter, both issued after the markets closed today. These documents are available on the investor relations section of our website at ir.freesia.com. As a reminder, Today's call is being recorded, and a replay will be available on our investor relations website at ir.freesia.com following the conclusion of this call. During today's call, we may make forward-looking statements, including statements regarding trends, our anticipated growth, our strategies, predictions about our industry, and the anticipated performance of our business, including our outlook regarding future financial results. Forward-looking statements are subject to various risks, uncertainties, and other factors that may cause our actual results, performance, or achievements to differ materially from those described in our forward-looking statements. Such risks are described more fully in our earnings press release, our stakeholder letter, and our risk factors included in our SEC filings, including in our annual report on Form 10-K that will be filed with the SEC tomorrow. the forward-looking statements made on this call will be based on our current views and expectations and speak only as of the date on which the statements are made. We undertake no obligation to update and expressly disclaim the obligation to update these forward-looking statements to reflect events or circumstances after the date of this call or to reflect new information or the occurrence of unanticipated events. We may also refer to certain financial measures not in accordance with generally accepted accounting principles such as adjusted EBITDA and free cash flow, in order to provide additional information to investors. These non-GAAP measures should be considered in addition to, and not as a substitute for, or in isolation from, our GAAP results. The reconciliation of GAAP to non-GAAP results may be found in our earnings press release and stakeholder letter, which were furnished with our Form 8K filed after the markets closed today with the SEC, and may also be found on our investor relations website at ir.freesia.com. I will now turn the call over to our CEO, Hyman Diggs.
Thank you, Balaji, and good evening, everyone. Thank you for joining Frisia's fourth quarter earnings call. I want to take a moment to acknowledge that 20 years ago, Evan and I founded Frisia. Our mission is making care easier every day. Our vision is for every person to be an active participant in their care. I'm so proud of what we've accomplished over these years and excited about where we are heading. I want to extend my appreciation to my teammates, our clients, partners, and stakeholders who continue to contribute to our success. I am excited about the new products we've introduced over the past several quarters that improve medication adherence and the overall patient and provider experience. We look forward to making these products more widely available to our existing network and new clients. In fiscal 2025, we achieved another milestone. The Frisia platform was used in approximately 14% of patient visits across the United States for approximately $170 million. I would like to congratulate and thank the Frisia team for a strong finish to the fiscal year, which is reflected in our earnings press release and stakeholder letter. Let me hand it over to Balaji to review some of the highlights of the fourth quarter results and review our outlook for fiscal 2026.
You're reading a preview of the PHR Q4 2025 earnings call.
Free account.